• 대한전기학회:학술대회논문집
• /
• 대한전기학회 2005년도 심포지엄 논문집 정보 및 제어부문
• /
• pp.36-38
• /
• 2005

Photodynamic diagnosis is a modern method for the fluorescence imaging of cancer. 5-ALA induced protoporphyrin IX fluorescence benefits the tumour selective accumulation of protoporphyrin ; therefore, tumours can be differentiated from healthy tissue. This paper develops Photodynamic diagnosis (PDD) system about ALA that apply tissue absorption coefficient. About other photosensitizer, application capacitate. In this paper, we will expect effective result by working PDD with PDT (photodynamic therapy) system that is a therapy device of cancer.

• Journal of Gastric Cancer
• /
• 제20권4호
• /
• pp.355-375
• /
• 2020

Selective accumulation of a photosensitizer and the subsequent response in only the light-irradiated target are advantages of photodynamic diagnosis and therapy. The limited depth of the therapeutic effect is a positive characteristic when treating surface malignancies, such as peritoneal carcinomatosis. For photodynamic diagnosis (PDD), adjunctive use of aminolevulinic acid- protoporphyrin IX-guided fluorescence imaging detects cancer nodules, which would have been missed during assessment using white light visualization only. Furthermore, since few side effects have been reported, this has the potential to become a vital component of diagnostic laparoscopy. A variety of photosensitizers have been examined for photodynamic therapy (PDT), and treatment protocols are heterogeneous in terms of photosensitizer type and dose, photosensitizer-light time interval, and light source wavelength, dose, and dose rate. Although several studies have suggested that PDT has favorable effects in peritoneal carcinomatosis, clinical trials in more homogenous patient groups are required to identify the true benefits. In addition, major complications, such as bowel perforation and capillary leak syndrome, need to be reduced. In the long term, PDD and PDT are likely to be successful therapeutic options for patients with peritoneal carcinomatosis, with several options to optimize the photosensitizer and light delivery parameters to improve safety and efficacy.

• 한국정보통신학회:학술대회논문집
• /
• 한국정보통신학회 2022년도 추계학술대회
• /
• pp.291-293
• /
• 2022

The preparation of dendritic molecule for photodynamic diagnosis (PDD) or photodynamic therapy (PDT) has been interested on design and synthesis of macromolecule toward a new generation. Herein, the binding site of polyether group is an important role on the construction of macromolecule toward a new generation. Therefore, we will be presented on the preparation of dendritic molecule having the binding site.

• 한국정보통신학회:학술대회논문집
• /
• 한국정보통신학회 2022년도 춘계학술대회
• /
• pp.391-393
• /
• 2022

The preparation of polynuclear metal dendritic molecule for photodynamic diagnosis(PDD) or photodynamic therapy(PDT) has been interested on design and synthesis of metal-to-metal long ranged macromolecule. Herein, imine bond or amide bond as chemical bond is an important role on the construction of energy transfer or electron transfer system. Therefore, we will be presented on the role of chemical bond for the preparation of polynuclear metal dendritic molecule.

• 한국정보통신학회:학술대회논문집
• /
• 한국정보통신학회 2021년도 추계학술대회
• /
• pp.646-648
• /
• 2021

The syntheses and properties of polynuclear metal complexes have been reported to develop the easy syntheses and noble photo-characteristics of those complexes for photodynamic diagnosis (PDD) or photodynamic therapy (PDT). We have been focused on the design and synthesis of polynuclear lanthanide dendritic molecule due to long life time of fluorescence. Therefore, we will be presented on the design of home (Eu or Gd) or hetero (Tb or Lu) polynuclear lanthanide dendritic molecule.

• 한국정보통신학회:학술대회논문집
• /
• 한국해양정보통신학회 2005년도 춘계종합학술대회
• /
• pp.1101-1103
• /
• 2005

최근 레이저 진단 및 치료의 동향, 즉 조직선택성을 갖는 레이저 치료와 새로운 광-조직 작용을 갖는 레이저 진단에 관하여 조사 발표하고, PDT 및 PDD의 새로운 연구발전 방향을 제시한다.

• 한국광학회:학술대회논문집
• /
• 한국광학회 2002년도 제13회 정기총회 및 2002년도 동계학술발표회
• /
• pp.223-233
• /
• 2002

• 전자공학회논문지SC
• /
• 제44권6호
• /
• pp.49-56
• /
• 2007

본 논문은 광역학적 암 진단에서 여기광원(excitation light)으로 사용되는 광원장치의 개발에 관한 연구이다. 여기광원의 파장 대 선택은 광과민제의 선택에 따라 형광발생과 상관관계를 가지게 된다. 따라서 본 연구에서는 다양한 광 과민제(photosensitizer)를 이용한 광역학적 암 진단이 가능하도록, 여러 파장 대 광(multi-wavelength)의 선택과 안정적으로 출력할 수 있는 광원장치를 설계하고 개발하였다. 개발된 광원장치는 제논램프(Xenon lamp)를 이용 하였으며, iris를 통한 광 출력제어와 여러 가지 파장대의 필터로 구성된 필터 휠(filter wheel)을 고안하고, 파장 대는 380-420nm 430-480nm, 480-560nm의 파장 대를 출력할 수 있도록 제작하였으며, 광 전달 효율을 높일 수 있도록 광원 전송부도 고안하였다. 개발된 광원장치는 한국식약청의 허가 기준에 맞추어 성능을 평가하였으며, 광 출력과 파장대의 특성을 조사하고 안정성을 검증하였다.

• 대한전기학회:학술대회논문집
• /
• 대한전기학회 2007년도 심포지엄 논문집 정보 및 제어부문
• /
• pp.73-76
• /
• 2007

Photodynamic diagnosis(PDD) is a method to diagnose the possibility of cancer, both by the principle that if a photosensitizer is injected into an organic tissue, it is accumulated in the tissue of a malignant tumor selectively after a specific period, and by a comparison of the intensity of the fluorescence of normal tissue with abnormal tissue after investigating the excitation light of a tissue with accumulated photosensitizer. Since the selection of the wavelength band of excitation light has an interrelation with fluorescence generation according to the selection of a photosencitizer, it plays an important role in POD. This study aims at designing and evaluating light source devices that can stably generate light with various kinds of wavelengths In order to make possible PDD using a photosensitizer and diagnosis using auto-fluorescence. The light source device was a Xenon lamp and filter wheel, composed of an optical output control through Iris and filters with several wavelength bands It also makes the inducement of auto-fluorescence possible because it is designed to generate a wavelength band of 380-400. The transmission part of the light source was, developed to enhance the efficiency of light transmission. To evaluate this light source device, the characteristics of the light output and wavelength band were verified. To validate the capability of this device as PDD the detection of auto-fluorescence using mouse was performed.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권6호
• /
• pp.2297-2301
• /
• 2015

Background: Despite widely adopted standard methods for follow-up including cystoscopy plus cytology, recurrence rates of non muscle-invasive bladder cancer (NMIBC) have not improved over the past decades, still ranging from 60% through 70%. Hence, widely acceptable surveillance strategies with excellent sensitivity are needed. Early recurrence has led to the development of a novel cystoscopy technique utilizing photodynamic diagnosis (PDD). Although, no studies have evaluated the efficacy of PDD for patients of MIBC, BCG failure or 2nd-transurethelial resection (TUR). Materials and Methods: The present study was performed from October 2012 through May 2013. IRB approved 25 patients initially underwent a cystoscopy examination of white light and blue light followed by the resection of tumors identified. Resections were performed from bladder mucosa areas considered suspicious at PDD, along with PDD negative normal bladder mucosa area resected by random biopsy. Specimens were divided into two groups, PDD positive and negative. Primary endpoints were sensitivity and specificity. Results: A total of 147 specimens extracted from 25 patients were included in the analysis. Some 45 out of 92 PDD-positive specimens were confirmed to have bladder cancer, and 51 out of PDD-negative 55 specimens were confirmed to be cancer negative. The sensitivity of PDD was 91.8% (45/49) and specificity was 52.0% (51/98). The sensitivity:specificity was 89.5% (17/19) : 47.6% (30/63) in 12 2nd-TUR patients, 90.5% (19/21) : 61.1% (11/18) in seven MIBC patients, and 95.0% (19/20) : 48.5% (16/33) in eight failed BCG cases. Conclusions: PDD-TURBT has high sensitivity to diagnose BC even for 2nd-TUR, MIBC or BCG failure cases.